Anteris Technologies Global Corp. (NASDAQ:AVR) Receives Average Rating of “Moderate Buy” from Brokerages

Shares of Anteris Technologies Global Corp. (NASDAQ:AVR) have been given a consensus rating of “Moderate Buy” by the five research firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and four have given a buy recommendation to the company. The average 1-year price objective among brokers that have covered the stock in the last year is $15.3333.

AVR has been the topic of a number of recent analyst reports. Wells Fargo & Company initiated coverage on shares of Anteris Technologies Global in a research report on Wednesday, March 11th. They issued an “overweight” rating and a $16.00 price target on the stock. Cantor Fitzgerald reissued an “overweight” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, March 27th. Barclays reissued an “overweight” rating on shares of Anteris Technologies Global in a research report on Friday. Finally, Lake Street Capital reissued a “buy” rating and issued a $15.00 price target on shares of Anteris Technologies Global in a research report on Friday, January 23rd.

Anteris Technologies Global Price Performance

Anteris Technologies Global stock opened at $7.25 on Friday. The company has a market capitalization of $705.72 million, a price-to-earnings ratio of -3.25 and a beta of 1.32. Anteris Technologies Global has a one year low of $2.85 and a one year high of $7.49. The company’s fifty day moving average price is $5.93 and its two-hundred day moving average price is $5.35.

Anteris Technologies Global (NASDAQ:AVR) last issued its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. The company had revenue of $0.49 million during the quarter, compared to the consensus estimate of $0.77 million. During the same period in the previous year, the business posted ($0.61) earnings per share. As a group, sell-side analysts anticipate that Anteris Technologies Global will post -1.54 earnings per share for the current year.

Hedge Funds Weigh In On Anteris Technologies Global

Several large investors have recently made changes to their positions in AVR. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. acquired a new position in shares of Anteris Technologies Global during the 1st quarter worth about $32,000. Geode Capital Management LLC lifted its position in shares of Anteris Technologies Global by 154.3% during the 2nd quarter. Geode Capital Management LLC now owns 420,427 shares of the company’s stock worth $1,593,000 after purchasing an additional 255,088 shares during the last quarter. JPMorgan Chase & Co. lifted its position in shares of Anteris Technologies Global by 9,958.6% during the 2nd quarter. JPMorgan Chase & Co. now owns 1,068,328 shares of the company’s stock worth $4,049,000 after purchasing an additional 1,057,707 shares during the last quarter. Nantahala Capital Management LLC lifted its position in shares of Anteris Technologies Global by 1.8% during the 2nd quarter. Nantahala Capital Management LLC now owns 1,693,666 shares of the company’s stock worth $6,419,000 after purchasing an additional 30,000 shares during the last quarter. Finally, Vanguard Group Inc. lifted its position in shares of Anteris Technologies Global by 85.1% during the 3rd quarter. Vanguard Group Inc. now owns 745,560 shares of the company’s stock worth $3,355,000 after purchasing an additional 342,711 shares during the last quarter.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.